Quick Links:
The COVID-19 pandemic has brought a huge impact on the global healthcare industry and awakened the public to the importance of healthcare. After the pandemic, the development opportunities of the healthcare industry, and how to seize them to enhance the efficiency and competitiveness of institutions and enterprises have become the key directions of the healthcare and medical industry.
With the continuous increase in China's per capita income and the trend of aging, the medical and health industry has ushered in historic development opportunities and has become one of the industries with the greatest development potential in China, with huge room for development. The continuous reform of the medical and health industry has brought a series of opportunities and challenges: The reform of the DRG/DIP payment method has put forward higher requirements for the refined management and efficiency improvement of medical service institutions; Volume-based purchasing has promoted a significant drop in drug prices, allowing medical insurance to tilt more toward innovative drugs and devices. Both medical institutions and medical companies need continuous innovation to enhance market competitiveness and adapt to changes in the medical market.
In addition, with the widespread application of big data, artificial intelligence and other technologies, the medical industry is undergoing a new era of digital transformation. By applying these technologies, medical institutions and enterprises can achieve more accurate diagnosis and treatment, and improve the quality and efficiency of medical services.
As managers of a medical service institution or medical-related enterprise, their management philosophy and operations' standard directly determine the prospects of development. This is especially important in today's healthcare industry, which places higher demands on the managers of healthcare institutions. Based on the actual situation and specific environment of healthcare institutions in Mainland China, this programme aims to combine the advantages of Hong Kong as a meeting point between Mainland China and the West with advanced foreign management theories to provide healthcare managers with latest industry knowldge as well as systematic and professional training, to think strategically about current healthcare management issues and challenges, to acquire modern management knowledge and leadership skills required for healthcare leaders, and to expand the network and contacts in general health industry.
Programme Objectives
该课程旨在培训现代医疗保健管理人员,传播现代医疗保健和卫生机构管理的新思想和方法。它使医疗保健和保健机构管理人员能够接受最新的行业知识以及系统和专业的培训,对当前的管理问题和挑战进行战略性思考,并获得医疗保健和健康行业领导者所需的现代管理知识和领导技能。
通过学习该课程,学生将能够:
- 分析医疗保健行业的内部和外部环境,并制定符合医疗改革和社会发展需求的机构发展战略。
- 为机构建立愿景,并规划和实施更具竞争力的战略计划。
- 建立有效的管理系统,分配和利用各种有限的资源,以刺激盈利能力。
- 利用信息资源和经济分析方法来提高领导层的决策能力。
- 在与医疗保健行业相关的医院或机构实施质量控制,提高危机管理能力。
- 利用尖端的商业知识,与不同的业务合作伙伴和社区建立良好的内部和外部关系。
- 了解 bid 数据和人工智能等新技术在健康行业的应用。
Programme Content
- Residential Workshop
- Healthcare Transformation and Innovation
- Healthcare Strategy and Operations Management
- Leadership and Team Building
- Healthcare Quality and Patient Relationship Management
- Digital Management of Healthcare Industry
- Health Technology Frontiers and Trends
- Healthcare Investment, Financing and M&A
- Finance and Cost Management
- Final Project
Professor Qualifications

陈肇始教授
Prof Sophia Siu-chee Chan
Academic Advisor & Honorary Professor, former Secretary of the Food and Health Bureau of Hong Kong, Internationally renowned nursing scientist, and the Director and Professor of the HKU Primary Health Care Academy (HKU PHCA)

管轶教授
Prof Yi Guan
Academic Advisor & Honorary Professor, Daniel CK Yu Professorship in Virology; Chair Professor of Emerging Viral Diseases, School of Public Health; Director of the State Key Laboratory of Emerging Infectious Diseases at the University of Hong Kong (HKU)

金冬雁教授
Prof Dong-yan Jin
Honorary Professor, Renowned virologist, Professor at the School of Biomedical Sciences of HKU, Senior Associate Dean (Graduate School) of HKU

廖锡尧教授
Prof Geoffrey Lieu
Adjunct Professor, Founder and Honorary Chairman of the Hong Kong Institute of Healthcare Policy, Fellow of the American College of Healthcare Executives (ACHE), former Chief Executive of the Hong Kong Hospital Authority

刘少怀医生
Dr Shao-haei Liu
Adjunct Professor, Founding President of Society for Innovative Healthcare Hong Kong, Former Chief Executive of Tuen Mun Hospital, and former Chief Manager (Administration) of the Hong Kong Hospital Authority

张彤教授
Prof Tong Zhang
Chair Professor of Environmental Engineering in Environmental Microbiome Engineering and Biotechnology Laboratory, Department of Civil Engineering, at the University of Hong Kong (HKU)

李咏梅教授
Prof Anne Lee
Honorary Professor, Deputy Hospital Chief Executive (Clinical Services) / Director of Centre for Oncology Medicine, The University of Hong Kong-Shenzhen Hospital

刘澎涛教授
Prof Pengtao Liu
S Y and H Y Cheng Professor in Stem Cell Biology and Regenerative Medicine

冼艺泉医生
Dr Ngai-chuen Sin
Adjunct Professor, Executive Director of Hong Kong Alice Ho Miu Ling Nethersole Hospital and Tai Po Hospital, Former General Manager (Patient Safety & Risk Management) of Hospital Authority Head Office

连祺周博士
Dr Qizhou Lian
Adjunct Professor, Researcher and PhD Supervisor at the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (CAS), Former Scientific Director of the GMP Facility for Stem Cell and Gene Therapy at HKU

何永基教授
Prof Joshua Wing Kei Ho
the Assistant Dean (Innovation & Technology Transfer), Co-Director of Master of Biomedical Innovation, Associate Professor in the Li Ka Shing Faculty of Medicine at the University of Hong Kong (HKU)

钱庆文教授
Prof Ching-Wen Chien
Professor at the Institute of Hospital Management, Tsinghua University

吴明彦先生
Mr Mingyen Wu
Adjunct Associate Professor, Secretary-General of Taiwan Non‑governmental Hospitals and Clinics Association, Consultant of Chang Gung Memorial Hospital

陈丽颖女士
Ms Liying Chen
Adjunct Associate Professor; Co-Dean (Chinese Programs), Asian Leadership & Management College, Duke-NUS Medical School; Senior Director of Education (Hospital Administration), SingHealth Duke-NUS Global Health Institute

许小虎博士
Dr Andrew Hui
Adjunct Associate Professor; General Manager and Chief Operating Officer, Canossa Hospital, Hong Kong; Former General Manager for Greater China of ALK-Abelló (Denmark)

徐伟翔博士
Dr Adam Chee
Adjunct Associate Professor, Chief of Smart Health Leadership Centre at National University of Singapore, Associate Professor of Saw Swee Hock School of Public Health of National University of Singapore

罗志强医生
Dr Chi Keung Law
Adjunct Associate Professor, University of Hong Kong; Former General Manager of Allied Health at Pamela Youde Nethersole Hospital in Hong Kong East District

黄潇博士
Dr Albert Huang
Adjunct Associate Professor, Managing Director at YF Capital, PhD in Cellular Pharmacology and Stem Cells from Yale University

张强医生
Dr Qiang Zhang
Adjunct Associate Professor, founder of Chinese Mainland’s first physician group, renowned specialist in venous disease
计划特色
内容:本项目理论结合实际,针对热点问题提出最新的管理理念,旨在帮助医护人员提高管理技能,解决实际医疗管理中存在的问题,全面提升医疗机构治理水平。
师资力量:本专业师资人员均来自医疗机关、公立医院和私立医院,具有丰富的管理经验,深谙中国文化,具有国际视野,融合了东西方先进的医疗管理经验。
海外游学:组织学生到海外知名学术机构学习,学习最先进的医疗保健理念和管理实践,以增强学生的国际视野和开阔视野。
课外活动:除了课堂学习外,还安排学生参观医疗机构、校友活动和文化活动,以增强他们的学习体验。
证书:国际认可的研究生文凭
中英文双语教学(英语讲座,中文传译)。通过评估的人将获得国际认可的研究生文凭。
入学要求
- 具有至少 10 年或以上的工作经验
- 持有认可的本科学位或同等学历
- 获得组织的推荐和支持或赞助
- 在组织内担任高级管理职位
毕业证书
完成「住宿工作坊」、8 个必修单元和「健康管理行政人员最终项目」后,并通过评估后,学生将获香港大学颁授研究生课程的「健康管理深造文凭」。
Fees and Charges
Tuition fee: | 468,000 HKD (2025-2026 Cohort) Remarks: The Institute will provide and arrange accommodation and meals (except dinner) for all modules offline and during the overseas study tour. Students are responsible for covering their own transportation, visa fees and other expenses, etc. Students may also opt out of the accommodation or meals arranged by the Institute but will be responsible for any costs incurred thereof. In addition, if, due to the pandemic or any other reasons and the above modules are completed online, or if the above accommodation and meals are not undertaken, the Institute will not refund any money to the student or cover any additional accommodation and meals. |
| To encourage alumni of the HKU Institute for China Business (HKU ICB) to practise the idea of "lifelong learning" and achieve higher career goals, HKU ICB has set up the "Lifelong Learning Scholarship" (HK$40,000 per eligible alumnus). ICB alumni who continue to strive for excellence will be supported to pursue further studies in a series of senior executive programmes such as the Executive Diploma programmes in partnership with the business school of the University of Cambridge, medical schools of prestigious academic institutions in the United States and Euromed Marseille Ecole de Management. | |
